...
首页> 外文期刊>The Prostate >Identification and characterization of neutral endopeptidase (EC 3. 4. 24. 11) from human prostasomes--localization in prostatic tissue and cell lines.
【24h】

Identification and characterization of neutral endopeptidase (EC 3. 4. 24. 11) from human prostasomes--localization in prostatic tissue and cell lines.

机译:来自人前列腺小体的中性内肽酶(EC 3. 4. 24. 11)的鉴定和表征-在前列腺组织和细胞系中的定位。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: An antibody directed against a 100 kDa protein was immunoselected from a polyvalent antiserum against human prostasomes. The antibody as well as biochemical characteristics of the respective antigen were used to study the structural relationship of the latter with prostate membrane specific antigen (PMSA), another 100 kDa membrane protein of the prostate. METHODS: The isolated purified 100 kDa protein was characterized by tryptic degradation, aminoacid-sequencing and mass spectroscopy peptide-fingerprinting as well as mono-saccharide analysis and lectin binding and identified as a prostasomal neutral endopeptidase (NEP, EC 3.4.24.11). Immunohistochemistry, immunoelectron microscopy, in situ hybridization, and RT-PCR were performed to analyze the expression and distribution of the protein in normal and malignant human prostatic tissues and cell lines. RESULTS: Prostatic NEP, which has no relationship with PMSA, is a glycosylated, integral membrane protein type II. The prevalent glycosyl residues are NeuNAc, GlcNAc, GalNAc, Gal, Man, Fuc. NEP-mRNA is expressed in human prostatic epithelial and some stromal cells. NEP-immunoreactivity is strong in normal prostatic epithelium and confined to the apical plasma membrane. During apocrine secretion, the enzyme is released from the secretory cells, contributing to the formation of prostasomes. In prostate cancer specimens, immunoreactivity of apical plasma membranes is lost, while generalized cytoplasmic immunoreactivity develops. CONCLUSIONS: Prostatic secretory cells contain a membrane-bound, highly glycosylated neutral endopeptidase which is restricted to the apical plasma membrane. The enzyme is released from the cells in an apocrine fashion and contributes to the formation of prostasomes. In prostate cancer cells a preferential cytoplasmic localization is observed, pointing to alterations in intracellular targeting. Copyright 2001 Wiley-Liss, Inc.
机译:背景:从针对人前列腺的多价抗血清中免疫选择了针对100 kDa蛋白的抗体。使用抗体以及相应抗原的生化特性来研究后者与前列腺膜特异性抗原(PMSA)(另一种100 kDa的前列腺膜蛋白)的结构关系。方法:分离的纯化的100 kDa蛋白具有胰蛋白酶降解,氨基酸测序和质谱指纹图谱以及单糖分析和凝集素结合的特点,并被鉴定为前体中性内肽酶(NEP,EC 3.4.24.11)。进行了免疫组织化学,免疫电子显微镜,原位杂交和RT-PCR分析该蛋白质在正常和恶性人类前列腺组织和细胞系中的表达和分布。结果:前列腺NEP与PMSA无关,是糖基化的完整膜蛋白II型。普遍的糖基残基是NeuNAc,GlcNAc,GalNAc,Gal,Man,Fuc。 NEP-mRNA在人前列腺上皮和某些基质细胞中表达。 NEP免疫反应在正常前列腺上皮中很强,并局限于顶质膜。在顶泌分泌过程中,酶从分泌细胞中释放出来,促成前体的形成。在前列腺癌标本中,根尖质膜的免疫反应性丧失,而普遍的细胞质免疫反应性发展。结论:前列腺分泌细胞含有膜结合的,高度糖基化的中性内肽酶,该酶仅限于顶端质膜。该酶以顶泌的方式从细胞中释放出来,并有助于形成前体。在前列腺癌细胞中,观察到优先的胞质定位,指出细胞内靶向的改变。版权所有2001 Wiley-Liss,Inc.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号